Tryptamine Therapeutics Ltd (TYP) Income Statement & Earnings

0.034
0.0000.00%

20min DelayMarket Closed Nov 20 15:54 AET

54.72MMarket Cap-8.50P/E (Static)

Tryptamine Therapeutics Ltd (TYP) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2025

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Total revenue

520.24%618.57K

99.73K

Operating revenue

----

520.24%618.57K

--99.73K

----

Cost of revenue

Gross profit

520.24%618.57K

99.73K

Operating expense

6.73M

-28.16%10.21M

12.20%14.21M

58.24%12.67M

237.52%8M

2.37M

Selling and administrative expenses

--4.28M

-32.85%6.5M

17.61%9.68M

71.73%8.23M

251.40%4.79M

--1.36M

-Selling and marketing expense

----

-67.66%93.8K

-12.35%290.07K

139.99%330.96K

--137.91K

----

-General and administrative expense

--4.28M

-31.77%6.41M

18.87%9.39M

69.71%7.9M

241.29%4.65M

--1.36M

Research and development costs

--2.4M

-31.67%1.73M

-19.93%2.54M

20.89%3.17M

427.34%2.62M

--496.69K

Depreciation amortization depletion

--54.34K

-1.56%1.7M

71.75%1.73M

163.16%1.01M

537.29%382.42K

--60.01K

-Depreciation and amortization

--54.34K

-1.56%1.7M

71.75%1.73M

163.16%1.01M

537.29%382.42K

--60.01K

Other operating expenses

----

2.71%276.74K

1.81%269.45K

25.35%264.65K

-53.21%211.14K

--451.28K

Operating profit

-6.73M

32.04%-9.59M

-11.41%-14.11M

-58.24%-12.67M

-237.52%-8M

-2.37M

Net non-operating interest income (expenses)

-1.8K

-300.58%-313.28K

-1,209.46%-78.21K

-88.36%7.05K

110.43%60.58K

28.79K

Non-operating interest income

--5.79K

494.44%17.95K

-57.17%3.02K

-88.36%7.05K

110.43%60.58K

--28.79K

Non-operating interest expense

--7.59K

307.79%331.23K

--81.23K

----

Other net income (expenses)

1.4M

-32.44%2.77M

-2.03%4.11M

57.26%4.19M

2.67M

Special income (charges)

---139.06K

----

-Less:Impairment of capital assets

--139.06K

----

Other non-operating income (expenses)

--1.54M

-32.44%2.77M

-2.03%4.11M

57.26%4.19M

--2.67M

----

Income before tax

-5.33M

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Income tax

Earnings from equity interest net of tax

Net income

-5.33M

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Net income continuous operations

---5.33M

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

---2.28M

Noncontrolling interests

Net income attributable to the company

-5.33M

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-5.33M

29.29%-7.13M

-19.08%-10.08M

-60.42%-8.47M

-131.23%-5.28M

-2.28M

Diluted earnings per share

-0.0039

36.26%-0.0905

0.93%-0.142

-15.30%-0.1433

-39.45%-0.1243

-0.0891

Basic earnings per share

-0.0039

36.26%-0.0905

0.93%-0.142

-15.30%-0.1433

-39.45%-0.1243

-0.0891

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2025	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Total revenue		520.24%618.57K	99.73K
Operating revenue	----	520.24%618.57K	--99.73K	----	----	----
Cost of revenue
Gross profit		520.24%618.57K	99.73K
Operating expense	6.73M	-28.16%10.21M	12.20%14.21M	58.24%12.67M	237.52%8M	2.37M
Selling and administrative expenses	--4.28M	-32.85%6.5M	17.61%9.68M	71.73%8.23M	251.40%4.79M	--1.36M
-Selling and marketing expense	----	-67.66%93.8K	-12.35%290.07K	139.99%330.96K	--137.91K	----
-General and administrative expense	--4.28M	-31.77%6.41M	18.87%9.39M	69.71%7.9M	241.29%4.65M	--1.36M
Research and development costs	--2.4M	-31.67%1.73M	-19.93%2.54M	20.89%3.17M	427.34%2.62M	--496.69K
Depreciation amortization depletion	--54.34K	-1.56%1.7M	71.75%1.73M	163.16%1.01M	537.29%382.42K	--60.01K
-Depreciation and amortization	--54.34K	-1.56%1.7M	71.75%1.73M	163.16%1.01M	537.29%382.42K	--60.01K
Other operating expenses	----	2.71%276.74K	1.81%269.45K	25.35%264.65K	-53.21%211.14K	--451.28K
Operating profit	-6.73M	32.04%-9.59M	-11.41%-14.11M	-58.24%-12.67M	-237.52%-8M	-2.37M
Net non-operating interest income (expenses)	-1.8K	-300.58%-313.28K	-1,209.46%-78.21K	-88.36%7.05K	110.43%60.58K	28.79K
Non-operating interest income	--5.79K	494.44%17.95K	-57.17%3.02K	-88.36%7.05K	110.43%60.58K	--28.79K
Non-operating interest expense	--7.59K	307.79%331.23K	--81.23K	----	----	----
Other net income (expenses)	1.4M	-32.44%2.77M	-2.03%4.11M	57.26%4.19M	2.67M
Special income (charges)	---139.06K	----	----	----	----	----
-Less:Impairment of capital assets	--139.06K	----	----	----	----	----
Other non-operating income (expenses)	--1.54M	-32.44%2.77M	-2.03%4.11M	57.26%4.19M	--2.67M	----
Income before tax	-5.33M	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Income tax	0	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-5.33M	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Net income continuous operations	---5.33M	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	---2.28M
Noncontrolling interests
Net income attributable to the company	-5.33M	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-5.33M	29.29%-7.13M	-19.08%-10.08M	-60.42%-8.47M	-131.23%-5.28M	-2.28M
Diluted earnings per share	-0.0039	36.26%-0.0905	0.93%-0.142	-15.30%-0.1433	-39.45%-0.1243	-0.0891
Basic earnings per share	-0.0039	36.26%-0.0905	0.93%-0.142	-15.30%-0.1433	-39.45%-0.1243	-0.0891
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"